-
When I was a medicine resident 40 years ago just as the first ICUs were being introduced, treatment for life-threatening bacterial infections consisted of antibiotics, control or removal of the primary source, intravenous fluids, and vasopressors.
-
Fresh ileum tissue specimens from infants with NEC or non-NEC diagnoses were provided by the Pathology departments at the children's hospitals at Vanderbilt and at University of Illinois. Standard methods of nucleic acid extraction were employed.
-
During November, 2011, I attended separate meetings dedicated to exploring the incidence of antimicrobial resistance in two areas of the developing world, India and Cambodia. The first, sponsored jointly by the American Society for Microbiology (ASM), the European Society for Clinical Microbiology and Infectious Diseases (ESCMID), and the Indian Association of Medical Microbiologists (IAMM), was named the "International Workshop on Antimicrobial Resistance" and was held at the Haffkine Institute in Mumbai, India. Organized by Prof. Lance Peterson (ASM representative), Prof. Abhay Chowdhary (Director of Haffkine Institute), Prof. V. Ravi (President of the IAMM), and Prof. Guiseppe Cornaglia (President of ESCMID), the workshop brought together around 250 participants, principally from India, to discuss various aspects of antimicrobial resistance over a 2.5 day program.
-
-
Sudden cardiac death (SCD) among postmenopausal women with coronary artery disease is common. The presence of congestive heart failure, reduced kidney function, atrial fibrillation, physical inactivity, and diabetes are independent risk factors for SCD. Some of these factors can be modified and SCD can be prevented.
-
This commentary challenges the urologic medical community to get past its "collective obsession with technology" and try to figure out why some surgeons have better outcomes, irrespective of the surgical approach taken.
-
-
For unknown reasons, adenocarcinoma of the esophagus (E-ca) is experiencing the most rapid increase of any known cancer in the United States.
-
Rivaroxaban, an oral factor XA inhibitor, has been approved for reducing the risk of stroke in patients with atrial fibrillation (AF). The drug joins dabigatran (Pradaxa) as the second "nonwarfarin" oral anticoagulant approved for this indication.
-
Eating chocolate may be part of a healthy lifestyle.